Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $1.78 Million - $2.12 Million
-12,500 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$135.08 - $161.1 $1.69 Million - $2.01 Million
12,500 New
12,500 $1.97 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Pinpoint Asset Management LTD Portfolio

Follow Pinpoint Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinpoint Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinpoint Asset Management LTD with notifications on news.